<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the expression of B cell-specific activator protein (BSAP)/Pax-5 in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: One hundred and two cases of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>), 3 cases of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), 3 cases of extranodal marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 1 case of nodular lymphocyte predominant Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e>), 10 cases of anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>) and 10 cases of <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> were studied immunohistochemically for BSAP and CD20 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells in the 102 cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> <z:hpo ids='HP_0000001'>all</z:hpo> expressed CD20, amongst which 100 cases also expressed BSAP </plain></SENT>
<SENT sid="3" pm="."><plain>Three cases of FL, 3 cases of extranodal marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and 1 case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NLPHL</z:e> also expressed BSAP and CD20 </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCLs</z:e> and <z:hpo ids='HP_0011857'>plasmacytomas</z:hpo> did not express BSAP and CD20 </plain></SENT>
<SENT sid="5" pm="."><plain>The expression rates of CD20 and BSAP were highly consistent </plain></SENT>
<SENT sid="6" pm="."><plain>The intensity of staining showed no statistical significance </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: BSAP/Pax-5 is a novel B-cell marker expressed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> nuclei of B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Though less sensitive than CD20, anti-BSAP has diagnostic value in routine surgical pathology practice </plain></SENT>
</text></document>